Rethinking Clinical Trials

MAY 19, 2023

It is difficult to enter and create visualizations of this data in the electronic health record (EHR), so the research team developed an EHR data visualization of home blood pressure from data entered via the patient portal. The team’s goals were to design for the primary care setting because 85% of hypertension care is in this setting.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Rethinking Clinical Trials

AUGUST 10, 2023

However, gamification could have serious negative effects, and the benefits of these games in health care would relate to how well or how poorly they’re gamified, based on data, execution, and use cases. What is going to keep AI in the boundaries for health hand research right now? People need to be really focused.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Medicine 130

Rethinking Clinical Trials

FEBRUARY 28, 2024

            Speakers Adrian Hernandez, MD Executive Director, Duke Clinical Research Institute Vice Dean, Duke University School of Medicine Christopher J. Solutions include a bi-directional EDC (electronic data capture system), MyChart for research, and active notifications to study personnel based on entered data.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

Rethinking Clinical Trials

AUGUST 18, 2022

The racism built into these categories does not go away when we do research. There are barriers at the health care professional and researcher level. When we say pragmatic = real world do we understand that health care in the real world is unfair, unjust, racist, discriminatory? Discussion Themes. New Ideas study.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Insulin 130

Rethinking Clinical Trials

JULY 27, 2022

Vice Dean for Clinical Research. There was some evidence of increased acute care needs (urgent care, emergency room visit) in the fluticasone furoate arm. One thing that has been a struggle is the diversity in the population and the equity in access to trials. Susanna Naggie, MD, MHS. Professor of Medicine. Key Points.

Trials 169

Trials Pharmacy Medicine Clinical Trials 169

Rethinking Clinical Trials

JANUARY 17, 2024

Any patient admitted to the hospital with COVID-19 completed a COVID intake form in their admission record, and if they opted to learn about experimental therapies, a FaceTime call was set up with a research coordinator.          Speaker Erin K. There was a daily process for the Remdesivir lottery.

Clinical Trials 169

Clinical Trials Clinical Trials Antibody Trials 169

Rethinking Clinical Trials

AUGUST 28, 2023

 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. I think collectively, we want to promote the utilization of health care in research.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

AUGUST 28, 2023

 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. I think collectively, we want to promote the utilization of health care in research.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Drug Discovery World

JANUARY 30, 2024

Lentivirus strategies are one of the most widely used tools in biomedical research and clinical testing, says Stella Vnook, CEO, Likarda. “Dr Joel Eichmann, Co-Founder and Managing Director, Green Elephant Biotech, agrees that prices need to come down significantly for CGT to be widely available.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

pharmaphorum

JANUARY 21, 2022

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Balancing the incentivisation of innovation against affordable access to revolutionary new medicines is an age-old conundrum in the biopharmaceutical industry.

Medicine 52

Medicine Marketing Manufacturing Production 52

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Regulation 91

Regulation Marketing Sales Branding 91

World of DTC Marketing

DECEMBER 13, 2021

OPENING: American cancer patients spent more than $21 billion on their care in 2019. As cancer survival rates rise, so do the price tags of life-saving treatments. Research shows most cancers are preventable. billion included out-of-pocket costs of $16.22 billion and patient time costs of $4.87

Drugs 55

Drugs FDA Approval Medicine Containment 55

Delveinsight

JULY 22, 2020

Today the tech-based healthcare industry is providing many unique solutions to the patient’s care which are more efficient and effective than the traditional services. The method of services delivery and design has transformed to the extent that people can access healthcare services from thousands of miles away with just a smartphone.

Doctors 59

Doctors Doctor Marketing Production 59

XTalks

AUGUST 23, 2021

This is not a debate on approval,” said Stacie Weninger, PhD, president of the F-Prime Biomedical Research Initiative, in a focused topic session on the impact of drug approval on future clinical trials held on Tuesday July 27. Trials must be designed to address the current standard of care,” said Dr. Grill. “We

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

XTalks

FEBRUARY 27, 2024

Rare Disease Day 2024, which falls on February 29 this year, is an opportunity to unite under a common cause: to bring attention to the challenges faced by those living with rare diseases and to push for advancements in research, treatment and policy. Sarepta hopes to clarify Elvidys’ effectiveness in older children in a confirmatory trial.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

Pharmaceutical Technology

JANUARY 27, 2023

Dr. James George, a research professor at the University of Oklahoma Health Sciences Center, said Cablivi “adds a new aspect to treatment, the prompt recovery of platelets and prompt resolution of transient neurologic symptoms”. The disorder has a reported annual incidence between 1.5 cases per million in Europe.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

pharmaphorum

JUNE 15, 2021

Can the biopharma industry step up again to shatter industry orthodoxy and create new pathways for innovation, access, and affordability? The research presents three key findings that suggest the industry can — and must — continue to play an active role in shaping the future. . But there is a silver lining. About the author.

Clinical Trials 90

Clinical Trials Clinical Trials Development Marketing 90

XTalks

DECEMBER 21, 2022

Additionally, advanced technologies like artificial intelligence (AI) and the adoption of digital tools in healthcare are allowing for improved treatments and care, and powerful research insights. These technologies are enabling a broader shift towards the digitalization of healthcare including clinical research.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

pharmaphorum

OCTOBER 4, 2022

During the first stage of the initiative, more than 2,000 research papers were published, 49 clinical trials were carried out, and more than 30 patents were filed through the support of the US National Cancer Institute (NCI). Building a bank. Up in the clouds. The entire process takes place in the physician’s office, alongside a clinician.

Biobanking 103

Biobanking Clinical Trials Clinical Trials Trials 103

Delveinsight

DECEMBER 3, 2020

The researchers have been searching for ways to stop the ageing process for millennia; however, such methods remain obscure. The researchers concentrated on the “Yamanaka factors,” which are four transcription factors—Oct4, Sox2, Klf4 and c-Myc. Reversing vision loss by rolling back the ageing clock.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

XTalks

MARCH 22, 2023

Our webinars have become a key vendor-selection tool for decision-makers across the drug development pipeline — from discovery to commercialization — which is why all ten of the top ten contract research organizations (CROs) have worked with Xtalks. Roche had been a majority stakeholder in Genentech since 1990. According to Dr. John K.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

The Pharma Data

MAY 15, 2021

Whatever you do, if you care about your health and freedom, don’t miss out on this opportunity to discover what might be the best weight loss and longevity solution in world history. Whether you use my free PentagonFit tracker, bonuses and Academy access for 5 days or 5 months, you’ll be eligible for our 100% money back guarantee.

Production 52

Production Containment Medicine Vaccination 52

The Pharma Data

MAY 4, 2021

These assumptions are guided by the trajectory of current infection rates in many parts of the world and the expected timeline for broad access to effective vaccines. Current 2021 financial guidance is presented below. . . First-quarter 2021 operational growth was primarily driven by: BNT162b2, which contributed $3.5 in December 2019; and.

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharmaceutical Technology

NOVEMBER 30, 2022

In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. However, there has recently been a boom in interest and research in anti-obesity therapeutics. However, there has recently been a boom in interest and research in anti-obesity therapeutics. Access to anti-obesity medications.

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. However, there has recently been a boom in interest and research in anti-obesity therapeutics. However, there has recently been a boom in interest and research in anti-obesity therapeutics. Access to anti-obesity medications.

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246